Generation of a new chimeric antigen receptor (CAR) to target CD23 expressed on B-chronic lymphocytic leukemia (B-CLL) cells

被引：0
|
作者：
Attianese, Greta Maria Paola Giordano [1 ]
Hoyos, Vera [2 ]
Savoldo, Barbara [2 ]
Marin, Virna [1 ]
Brandi, Malika [1 ]
Biondi, Andrea [1 ]
Biagi, Ettore [1 ]
Dotti, GianPietro [2 ]
机构：
[1] Univ Milano Bicocca, Dept Pediat, M Tettamanti Res Ctr, Monza, Italy
[2] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
来源：
HUMAN GENE THERAPY | 2008年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
下载
收藏
页码：1136 / 1136
页数：1
相关论文
共 50 条
  • [31] Combining CD23 chimeric antigen receptor immunotherapy and lenalidomide as a novel therapeutic strategy for chronic lymphocytic leukemia
    Tettamanti, Sarah
    Galletti, Giovanni
    Attianese, Greta Maria Paola Giordano
    Arcangeli, Silvia
    Rodriguez, Tania Veliz
    Magnani, Chiara Francesca
    Barbaglio, Federica
    Scarfo, Lydia
    Ponzoni, Maurilio
    Biondi, Andrea
    Caligaris-Cappio, Federico
    Biagi, Ettore
    Ghia, Paolo
    Bertilaccio, Maria Teresa Sabrina
    LEUKEMIA & LYMPHOMA, 2015, 56 : 1 - 1
  • [32] Inhibition of spontaneous apoptotic cell death of B-chronic lymphocytic leukemia (B-CLL) cells by interleukin-12 in vitro
    Duensing, S
    Schuhknecht, S
    Franzke, A
    Buer, J
    ProbstKepper, M
    Hoffmann, R
    Ganser, A
    Atzpodien, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1200 - 1200
  • [33] Clinical significance of membrane antigen CD23 positivity in B chronic lymphocytic leukemia.
    Colovic, M
    Kraguljac, N
    Colovic, N
    Jankovic, G
    BLOOD, 2001, 98 (11) : 358A - 358A
  • [34] Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
    Tania Calvo
    Chantal Reina-Ortiz
    David Giraldos
    María Gascón
    Daniel Woods
    Judit Asenjo
    Joaquín Marco-Brualla
    Gemma Azaceta
    Isabel Izquierdo
    Luis Palomera
    Diego Sánchez-Martínez
    Isabel Marzo
    Javier Naval
    Carlos Vilches
    Martín Villalba
    Alberto Anel
    Scientific Reports, 10
  • [35] Expanded and activated allogeneic NK cells are cytotoxic against B-chronic lymphocytic leukemia (B-CLL) cells with sporadic cases of resistance
    Calvo, Tania
    Reina-Ortiz, Chantal
    Giraldos, David
    Gascon, Maria
    Woods, Daniel
    Asenjo, Judit
    Marco-Brualla, Joaquin
    Azaceta, Gemma
    Izquierdo, Isabel
    Palomera, Luis
    Sanchez-Martinez, Diego
    Marzo, Isabel
    Naval, Javier
    Vilches, Carlos
    Villalba, Martin
    Anel, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
    Bairey, O
    Zimra, Y
    Rabizadeh, E
    Shaklai, M
    BLOOD, 2001, 98 (11) : 281B - 281B
  • [37] Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia
    Mad'arova, Martina
    Mucha, Rastislav
    Hresko, Stanislav
    Makarova, Zuzana
    Gdovinova, Zuzana
    Szilasiova, Jarmila
    Vitkova, Marianna
    Guman, Tomas
    Stecova, Natalia
    Dobransky, Tomas
    LEUKEMIA RESEARCH, 2018, 70 : 25 - 33
  • [38] Intravenous immunoglobulin (IVIG) administration in B-chronic lymphocytic leukemia (B-CLL): Impact on disease activity.
    Vassilakopoulos, TP
    Angelopoulou, MK
    Pangalis, GA
    BLOOD, 1996, 88 (10) : 3615 - 3615
  • [39] Aberrant expression of trail in B chronic lymphocytic leukemia (B-CLL) cells.
    Tiribelli, M
    Barbarotto, E
    Celeghini, C
    Michelutti, A
    Zauli, G
    Fanin, R
    Secchiero, P
    BLOOD, 2005, 106 (11) : 325B - 325B
  • [40] TREATMENT OF ANEMIA IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO)
    PANGALIS, GA
    POZIOPOULOS, C
    PANAYIOTIDIS, P
    ANGELOPOULOU, M
    BLOOD, 1993, 82 (10) : A574 - A574
12345